Fennec Pharmaceuticals Inc

NASDAQ:FENC   12:13:04 AM EDT
9.55
-0.02 (-0.21%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)250.57M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.8 Million
Adjusted EPS-$0.26
See more estimates
10-Day MA$9.63
50-Day MA$8.43
200-Day MA$6.72
See more pivots

Fennec Pharmaceuticals Inc Stock, NASDAQ:FENC

Research Triangle Park, 68 T.W. Alexander Drive, Durham, North Carolina 27709
Canada
Phone: +1.919.636.4530
Number of Employees: 10

Description

Fennec Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development of sodium thiosulfate for the prevention of ototoxicity from cisplatin in pediatric cancer patients. The company was founded by Orest W. Blaschuk on September 3, 1996 and is headquartered in Durham, NC.